DASA3 logo

Diagnósticos da América S.A. Stock Price

BOVESPA:DASA3 Community·R$5.0b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

DASA3 Share Price Performance

R$4.19
2.35 (127.72%)
R$4.00
Fair Value
R$4.19
2.35 (127.72%)
4.8% overvalued intrinsic discount
R$4.00
Fair Value
Price R$4.19
AnalystHighTarget R$4.00

DASA3 Community Narratives

AnalystHighTarget·
Fair Value R$4 4.8% overvalued intrinsic discount

Premium And Home Care Diagnostics Will Drive A Stronger Long-Term Outlook

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
R$4
4.8% overvalued intrinsic discount
Revenue
-6.86% p.a.
Profit Margin
1.1%
Future PE
74.04x
Price in 2028
R$6.6

Trending Discussion

Updated Narratives

DASA3 logo

Premium And Home Care Diagnostics Will Drive A Stronger Long-Term Outlook

Fair Value: R$4 4.8% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Adequate balance sheet with low risk.

3 Risks
0 Rewards

Diagnósticos da América S.A. Key Details

R$12.6b

Revenue

R$9.0b

Cost of Revenue

R$3.6b

Gross Profit

R$4.6b

Other Expenses

-R$1.0b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Mar 26, 2026
-0.82
28.60%
-8.16%
110.4%
View Full Analysis

About DASA3

Founded
1961
Employees
n/a
CEO
Rafael Lucchesi
WebsiteView website
www.dasa3.com.br

Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. It operates through Hospitals and Oncology; Diagnostics and Care Coordination; and International Diagnostics segments. The company offers outpatient doctors; medical and outpatient services; diagnostic support assistants for private patients or partner companies; care coordination, remote monitoring, population health management, home medical, and paramedical services; and medical consultations. It is also involved in the development and licensing of computer programs and predictive models using information technology and data science; and brokerage activities. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in Barueri, Brazil.

Recent DASA3 News & Updates

There's Reason For Concern Over Diagnósticos da América S.A.'s (BVMF:DASA3) Massive 68% Price Jump

Dec 13
There's Reason For Concern Over Diagnósticos da América S.A.'s (BVMF:DASA3) Massive 68% Price Jump

Recent updates

No updates